![]() |
市場調查報告書
商品編碼
1916712
益生菌和益生元市場預測至2032年:按產品、來源、劑型、通路、應用、最終用戶和地區分類的全球分析Probiotic & Prebiotic Market Forecasts to 2032 - Global Analysis By Product (Probiotics and Prebiotics), Source, Form, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球益生菌和益生元市場價值將達到 653.4 億美元,到 2032 年將達到 1,049.2 億美元,在預測期內的複合年成長率為 7.0%。
益生菌和益生元是互補成分,共同維持健康的腸道菌叢和整體健康。益生菌是活的、有益的微生物,常見於發酵食品和膳食補充劑中,有助於平衡腸道菌叢、改善消化、增強免疫力並促進代謝健康。益生元則是不可消化的膳食纖維和化合物,它們為這些有益微生物提供營養,促進其在腸道內的生長和活性。益生菌和益生元的結合可產生協同效應,改善營養吸收、增強免疫功能、調節腸道菌叢,並有助於長期消化器官系統的平衡和健康。
人們對腸道環境的興趣日益濃厚
益生菌和益生元市場的發展主要得益於人們對腸道健康與整體健康之間聯繫的認知不斷提高。消費者越來越意識到消化平衡在免疫、代謝和心理健康方面的重要作用。這種認知,加上臨床研究和醫療建議的支持,正在推動對機能性食品、膳食補充劑和強化產品的需求。隨著人們生活方式的健康意識增強,預防保健的重要性日益凸顯,益生菌和益生元不再是小眾產品,而是成為全球市場日常營養的重要組成部分。
生產和倉儲成本高
高昂的生產和儲存成本仍是阻礙因素市場發展的主要因素。益生菌需要受控的生產環境、先進的發酵過程和嚴格的溫度控制才能維持微生物的活性。此外,低溫運輸物流和特殊包裝也會增加營運成本。這些因素推高了產品價格,並限制了成本敏感地區的市場進入。如何在確保品質的同時控制成本,一直是製造商面臨的挑戰,這可能會阻礙市場滲透。
創新和產品多元化
創新和產品多元化正在為益生菌和益生元市場創造巨大的機會。製造商正在開發新型菌株、合益素配方以及新的產品形式,例如軟糖、飲料和強化食品。個人化營養、微生物組研究和植物來源食品替代品的進步進一步擴大了市場潛力。這些創新使企業能夠瞄準不同的消費群體,包括兒童、老年人和運動員。隨著科學和消費者偏好的不斷發展,差異化產品正成為競爭激烈的全球市場中的關鍵驅動力。
監管挑戰
監管挑戰對市場構成重大威脅。各地在健康聲明、標籤和菌株核准方面的法規差異,為全球製造商帶來了許多複雜問題。嚴格的合規要求可能會延遲產品上市並增加研發成本。此外,科學檢驗標準的不一致也可能限制行銷的柔軟性。隨著監管機構加強審查以確保消費者安全,企業必須謹慎應對不斷變化的監管環境,才能在這個快速成長的市場中保持信譽並實現長期發展。
新冠疫情加速了消費者對免疫力和預防保健的關注,從而對市場產生了積極影響。消費者對支持消化系統健康和免疫力維護的產品,尤其是膳食補充劑和機能性食品的需求激增。然而,供應鏈中斷和原料短缺暫時影響了生產和分銷。儘管面臨這些挑戰,疫情提高了人們的長期健康意識,從而在疫情後保持了持續的需求,並強化了益生菌和益生元在全球日常健康生活中的重要作用。
預計在預測期內,軟糖類產品將佔據最大的市場佔有率。
由於其便利性、偏好口感和易服用性,預計在預測期內,軟糖產品將佔據最大的市場佔有率。軟糖深受兒童、成人和老年消費者的喜愛,他們正在尋找膠囊和粉末的替代品。軟糖誘人的口味和形式有助於提高遵守用藥和每日攝取量。此外,製造商在不影響功效的前提下,不斷採用先進的配方技術,使益生菌和益生元軟糖成為全球市場主導且深受消費者歡迎的產品類型。
預計在預測期內,製藥業將呈現最高的複合年成長率。
由於益生菌和益生元的臨床療效不斷檢驗,並在醫療保健領域廣泛應用,預計在預測期內,醫藥領域將呈現最高的成長率。其成長主要得益於益生菌和益生元在胃腸道疾病、免疫調節和抗生素相關疾病等治療應用中的日益普及。醫療專業人員會開立藥用級製劑,因為其劑量標準化且療效已得到證實。隨著研究的深入和監管核准的增加,醫藥應用預計將快速成長,從而提升該領域在整體市場佔有率中的比例。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於該地區人口密度高、中產階級收入不斷成長以及發酵食品在文化上被廣泛接受,這些因素將促進發酵食品的普及。健康意識的提高、膳食補充劑行業的擴張以及都市化進程的加速將進一步推動市場需求。此外,中國、日本和印度等國家機能性食品消費量的快速成長,已使亞太地區成為益生菌和益生元的主要區域市場。
在預測期內,北美地區預計將實現最高的複合年成長率,這主要得益於其先進的醫療保健基礎設施和消費者對腸道健康的高度關注。對膳食補充劑、機能飲料和藥用級產品的強勁需求正在推動市場快速成長。持續的創新、廣泛的臨床研究以及零售和線上通路的廣泛覆蓋,都為市場的進一步擴張提供了支持。該地區對預防性醫療保健和個人化營養的重視,使北美成為益生菌和益生元市場的主要成長引擎。
According to Stratistics MRC, the Global Probiotic & Prebiotic Market is accounted for $65.34 billion in 2025 and is expected to reach $104.92 billion by 2032 growing at a CAGR of 7.0% during the forecast period. Probiotics and prebiotics are complementary components that support a healthy gut microbiome and overall well-being. Probiotics are live beneficial microorganisms, commonly found in fermented foods and dietary supplements, that help balance intestinal bacteria, improve digestion, enhance immunity, and support metabolic health. Prebiotics, on the other hand, are non-digestible fibers and compounds that serve as nourishment for these beneficial microbes, stimulating their growth and activity in the gut. When combined, probiotics and prebiotics work synergistically to improve nutrient absorption, strengthen immune function, regulate gut health, and contribute to long-term digestive balance and wellness.
Growing Awareness of Gut Health
The probiotic and prebiotic market is strongly driven by growing awareness of gut health and its connection to overall wellness. Consumers increasingly recognize the role of digestive balance in immunity, metabolism, and mental health. This awareness, supported by clinical research and healthcare recommendations, has fueled demand for functional foods, supplements, and fortified products. As lifestyles become more health-conscious and preventive care gains importance, probiotics and prebiotics are no longer niche products but staples in daily nutrition routines across global markets.
High Production & Storage Costs
High production and storage costs remain a significant restraint for the market. Probiotics require controlled manufacturing environments, advanced fermentation processes, and strict temperature regulation to maintain microbial viability. Additionally, cold-chain logistics and specialized packaging increase operational expenses. These factors raise product prices, limiting accessibility in cost-sensitive regions. For manufacturers, maintaining quality while managing costs poses ongoing challenges, which can restrict market penetration.
Innovation & Product Diversification
Innovation and product diversification present substantial opportunities for the probiotic and prebiotic market. Manufacturers are developing novel strains, synbiotic formulations, and delivery formats such as gummies, beverages, and fortified foods. Advances in personalized nutrition, microbiome research, and plant-based alternatives further expand market potential. These innovations allow companies to target diverse consumer groups, including children, seniors, and athletes. As science and consumer preferences evolve, differentiated products are becoming key growth drivers in competitive global markets.
Regulatory Challenges
Regulatory challenges pose a notable threat to the market. Varying regulations across regions regarding health claims, labeling, and strain approval create complexities for global manufacturers. Strict compliance requirements can delay product launches and increase development costs. Additionally, inconsistent scientific validation standards may limit marketing flexibility. As authorities tighten oversight to ensure consumer safety, companies must navigate evolving regulatory landscapes carefully to sustain credibility and long-term growth in this rapidly expanding market.
The COVID-19 pandemic positively influenced the market by accelerating consumer focus on immunity and preventive healthcare. Demand surged for products supporting digestive health and immune resilience, particularly supplements and functional foods. However, supply chain disruptions and raw material shortages temporarily affected production and distribution. Despite these challenges, the pandemic reinforced long-term health awareness, leading to sustained post-COVID demand and strengthening the role of probiotics and prebiotics in daily wellness routines worldwide.
The gummies segment is expected to be the largest during the forecast period
The gummies segment is expected to account for the largest market share during the forecast period, due to their convenience, palatable taste, and ease of consumption. Gummies appeal strongly to children, adults, and elderly consumers who prefer alternatives to capsules or powders. Their attractive flavors and formats improve compliance and daily intake consistency. Additionally, manufacturers are incorporating advanced formulations without compromising efficacy, making probiotic and prebiotic gummies a dominant and consumer-friendly product category in the global market.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to rising clinical validation and medical adoption of probiotics and prebiotics. Increasing use in therapeutic applications such as gastrointestinal disorders, immune modulation, and antibiotic-associated conditions supports growth. Healthcare professionals are prescribing pharmaceutical-grade formulations due to standardized dosages and proven efficacy. As research expands and regulatory approvals increase, pharmaceutical applications are expected to grow rapidly, strengthening this segment's contribution to overall market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to high population density, growing middle-class income, and strong cultural acceptance of fermented foods support widespread adoption. Rising health awareness, expanding nutraceutical industries, and increasing urbanization further drives demand. Additionally, countries such as China, Japan, and India are witnessing rapid growth in functional food consumption, positioning Asia Pacific as a dominant regional market for probiotics and prebiotics.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure and high consumer awareness of gut health. Strong demand for dietary supplements, functional beverages, and pharmaceutical-grade products fuels rapid growth. Continuous innovation, extensive clinical research, and widespread availability across retail and online channels further support expansion. The region's focus on preventive healthcare and personalized nutrition makes North America a key growth engine for the probiotic and prebiotic market.
Key players in the market
Some of the key players in Probiotic & Prebiotic Market include Nestle, Danone, Yakult Honsha, Ingredion Incorporated, Chr. Hansen, Roquette Freres, DuPont de Nemours, Lallemand, Kerry Group, BioGaia, Archer Daniels Midland Company (ADM), Probi AB, Cargill, Lifeway Foods, and BENEO GmbH.
In October 2025, Nestle Saudi Arabia and King Abdullah University of Science and Technology (KAUST) signed a strategic MoU this partnership blends KAUST's world-class research excellence with Nestle's global food technology know-how to promote sustainability, food safety, and healthier lifestyles, supporting Saudi Vision 2030 goals while enhancing public health, food security, and local knowledge development.
In July 2025, Nestle and IBM Research have woven old-world stewardship with cutting-edge AI, creating a generative tool that can dream up new high-barrier packaging materials-shielding products from moisture, oxygen and heat while pushing sustainability forward faster than years of lab work.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.